financetom
Business
financetom
/
Business
/
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US
May 13, 2024 6:39 AM

09:07 AM EDT, 05/13/2024 (MT Newswires) -- Novo Nordisk ( NVO ) , based in Denmark, has been asked by Bernie Sanders of Vermont to reduce the prices of its Ozempic and Wegovy drugs in the US, multiple media outlets reported Monday, citing a column published by the US senator in Danish newspaper Politiken.

Ozempic costs 6,700 Danish kroner ($969.6) per month in the US, while it is sold for less than 500 kroner in other countries, Sanders wrote in the column for Politiken.

Sanders urged Denmark's government to put pressure on Novo Nordisk ( NVO ) to lower the prices of the two drugs, the outlets reported, citing the column.

Neither Novo Nordisk ( NVO ) nor the senator's office immediately responded to MT Newswires' requests for comment.

Price: 131.40, Change: +2.98, Percent Change: +2.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved